United States · Bill · HR
H.R. 5589 (101st)
Medicaid Prescription Drug Fair Access and Pricing Act of 1990
Introduced
12 September 1990
Last action
28 September 1990 · Referred
Status
Referred to the Subcommittee on Health and the Environment.
Sponsors
Sen. Wyden, Ron [D-OR], Rep. Cooper, Jim [D-TN-5], Rep. Slattery, Jim [D-KS-2], Rep. Kleczka, Gerald D. [D-WI-4], Rep. Rahall, Nick J., II [D-WV-3], Rep. Stark, Fortney Pete [D-CA-13], Rep. Collins, Cardiss [D-IL-7], Rep. Gordon, Bart [D-TN-6], Rep. Kaptur, Marcy [D-OH-9], Rep. Mrazek, Robert J. [D-NY-3], Rep. Bryant, John W. [D-TX-5], Rep. Hertel, Dennis M. [D-MI-14], Rep. Hughes, William J. [D-NJ-2], Rep. Lipinski, William O. [D-IL-3], Rep. Pelosi, Nancy [D-CA-11], Rep. Rangel, Charles B. [D-NY-15], Rep. Morrison, Bruce A. [D-CT-3], Sen. Markey, Edward J. [D-MA], Rep. Evans, Lane [D-IL-17], Rep. Costello, Jerry F. [D-IL-12], Rep. Vento, Bruce F. [D-MN-4], Rep. Jontz, Jim [D-IN-5], Rep. Alexander, Bill [D-AR-1]
Subjects
Healthcare
Source updated
3 June 2026
Summary
Medicaid Prescription Drug Fair Access and Pricing Act of 1990 - Amends title XIX (Medicaid) of the Social Security Act to condition Medicaid coverage of outpatient drugs provided by a manufacturer upon such manufacturer providing a quarterly rebate to each State Medicaid agency so that such agencies end up spending no more for single source and innovator multiple source drugs than the best price charged other customers and recover, for the purchase of other covered drugs, ten percent of the amount charged retail pharmacies and wholesalers for such drugs. Sets the best price at the lower of the best price in the marketplace when the drug is dispensed or the best price in the marketplace as of September 1, 1990, indexed to the consumer price index. Sets a floor and ceiling on manufacturer rebates. Authorizes a physician to obtain prior Medicaid approval to dispense a single source or innovator multiple source drug that is not subject to a rebate. Requires Medicaid prior approval programs to operate 24 hours a day and provide an immediate response to a physician's inquiry. Requires each State to develop a drug review program, by January 1, 1993, to assure that prescriptions are appropriate, medically necessary, and unlikely to result in adverse medical results. Includes prospective and retrospective drug prescription review and physician and pharmacist education in such program. Provides enhanced Federal funding of the cost of such programs. Provides that this Act does not require States to provide Medicaid coverage for the covered outpatient drugs of a manufacturer which requires, as a condition for the purchase of such drugs, that the manufacturer be paid for associated services or tests provided only by the manufacturer or its designee. Directs the Secretary of Health and Human Services to conduct a study on the therapeutic interchangeability of drugs.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 September 1990
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
12 September 1990
Introduced
Introduced in House
Source: IntroReferral
12 September 1990
Introduced
Introduced in House
Source: IntroReferral
28 September 1990
Referred
Referred to the Subcommittee on Health and the Environment.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · — · Download file
Documents
2 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN
Introduced in House
summary · EN · 12 September 1990
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Sen. Wyden, Ron [D-OR] · D · Sponsor
- Rep. Cooper, Jim [D-TN-5] · D · Sponsor
- Rep. Slattery, Jim [D-KS-2] · D · Cosponsor
- Rep. Kleczka, Gerald D. [D-WI-4] · D · Cosponsor
- Rep. Rahall, Nick J., II [D-WV-3] · D · Cosponsor
- Rep. Stark, Fortney Pete [D-CA-13] · D · Cosponsor
- Rep. Collins, Cardiss [D-IL-7] · D · Cosponsor
- Rep. Gordon, Bart [D-TN-6] · D · Cosponsor
- Rep. Kaptur, Marcy [D-OH-9] · D · Cosponsor
- Rep. Mrazek, Robert J. [D-NY-3] · D · Cosponsor
- Rep. Bryant, John W. [D-TX-5] · D · Cosponsor
- Rep. Hertel, Dennis M. [D-MI-14] · D · Cosponsor
- Rep. Hughes, William J. [D-NJ-2] · D · Cosponsor
- Rep. Lipinski, William O. [D-IL-3] · D · Cosponsor
- Rep. Pelosi, Nancy [D-CA-11] · D · Cosponsor
- Rep. Rangel, Charles B. [D-NY-15] · D · Cosponsor
- Rep. Morrison, Bruce A. [D-CT-3] · D · Cosponsor
- Sen. Markey, Edward J. [D-MA] · D · Cosponsor
- Rep. Evans, Lane [D-IL-17] · D · Cosponsor
- Rep. Costello, Jerry F. [D-IL-12] · D · Cosponsor
- Rep. Vento, Bruce F. [D-MN-4] · D · Cosponsor
- Rep. Jontz, Jim [D-IN-5] · D · Cosponsor
- Rep. Alexander, Bill [D-AR-1] · D · Cosponsor
- · hsif00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/101st-congress/house-bill/5589
- Open data entity: https://api.congress.gov/v3/bill/101/hr/5589
- us · 101-hr-5589 · source updated 3 June 2026